Evidence map›Paper›PMID 33082835›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Effect of Cuttlebone on Healing of Indomethacin-Induced Acute Gastric Mucosal Lesions in Rats.

Lifeng Qiu, Lingya Yao, Yanfei Fang, Lan Wang, Meng Xue, Zhenghua Lin, Shujie Chen, Jianmin Si

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lifeng QiuDepartment of General Practice, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Lingya YaoInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-5850-1217
Yanfei FangInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Lan WangInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Meng XueInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Zhenghua LinInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Shujie ChenInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.
Jianmin SiInstitute of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang 310000, China.ORCID https://orcid.org/0000-0002-1254-7949

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuing use of nonsteroidal anti-inflammatory drugs (NSAIDs) usually increases the side effects such as peptic ulcer and acute gastric lesions in the gastrointestinal tract. Cuttlebone (CB), isolated from Sepiella maindroni de Rochebrune, was reported to have antioxidant activities, but its role in the treatment of indomethacin-induced gastric lesions has not yet been confirmed. In this research, we investigate the protective effect of cuttlebone on indomethacin-related ulcers in rats and possible mechanisms. Here, gastric ulcers were induced by oral administration of indomethacin, and then the rats were treated with omeprazole (4 mg/kg) or different doses (750, 1500, and 3000 mg/kg of body weight) of cuttlebone. We evaluated lesion index, inflammation score, and a series of oxidant/antioxidant parameters. The data demonstrated that cuttlebone could protect against gastric ulcers induced by indomethacin in a dose-dependent manner (positive correlation). Also, these effects were associated with attenuating the expression of malonaldehyde (MDA) and increasing the levels of some protective ingredients like epidermal growth factor (EGF), prostaglandin E2 (PGE2), and superoxide dismutase (SOD). Thus, considering its ability to protect indomethacin-induced acute gastric mucosal lesions and the underlying mechanisms, CB might be a potential candidate for treating gastric damage caused by NSAIDs.

Identifiers

PMID33082835
PMCPMC7563050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.